A Regulatory Guide to Post-Market Surveillance
Post-Market Surveillance (PMS) according to MDR 2017/745 and IVDR 2017/746 is a systematic process to continuously monitor the safety and…
Congenius
Post-Market Surveillance (PMS) according to MDR 2017/745 and IVDR 2017/746 is a systematic process to continuously monitor the safety and…
Congenius
In the realm of medical technology and innovation, the development and production of safe and effective medical devices is of…
Congenius
With extensive conversation and conjecture around Artificial Intelligence, it’s easy to lose sight of the technology’s true relevance to the…
Congenius
A successful business must constantly adapt to a changing environment. Markets, economic and political frameworks, technology – they permanently undergo…
Congenius
In the European Union, a rare disease is defined as one that affects no more than 1 person in 2,000,…
Congenius
Last year in our topical article How to optimize your supplier management, we examined the key issues, challenges, and opportunities…
Congenius
Artificial Intelligence (AI) has the potential to revolutionise the healthcare industry by enhancing diagnostic accuracy, treatment efficiency, and patient care.…
Congenius
The lack of diversity in healthcare is a topic that’s been written about for at least the last two decades.…
Congenius